✦ LIBER ✦

Effect of the dual 5α-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia

✍ Scribed by Sung Kyu Hong; Gyeong Eun Min; Seung Bum Ha; Seung Hwan Doo; Min Yong Kang; Hong Joo Park; Cheol Yong Yoon; Seong Jin Jeong; Seok-Soo Byun; Sang Eun Lee

Book ID: 109056189
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 210 KB
Volume: 105
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2009.08915.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term therapy with the dual 5α-reduc

Long-term therapy with the dual 5α-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia

✍ CLAUDE SCHULMAN; PETER POMMERVILLE; KLAUS HÖFNER; BARTON WACHS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Long-term sustained improvement in sympt

Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5α-reductase inhibitor dutasteride: results of 4-year studies

✍ Claus G. Roehrborn; Olavi Lukkarinen; Stephen Mark; Paul Siami; Joe Ramsdell; No 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Effects of the dual 5 α-reductase inhibi

Effects of the dual 5 α-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines

✍ Ann Maria McCrohan; Colm Morrissey; Conor O'Keane; Niall Mulligan; Chanel Watson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB